Depressive symptoms following interferon- therapy: Mediated by immune-induced reductions in brain-derived neurotrophic factor?

International Journal of Neuropsychopharmacology

Volumn 14, Issue 2, 2011, Pages 247-253

  Kenis, Gunter ^a,f   Prickaerts, Jos ^a,f   Van Os, Jim ^a,f   Koek, Ger H ^b   Robaeys, Geert ^c,d,e   Steinbusch, Harry W M ^a,f   Wichers, Marieke ^a,f  

^a MAASTRICHT UNIVERSITY   (Netherlands)

^b MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

^c DEPARTMENT OF CARDIOLOGY   (Belgium)

^d UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^e HASSELT UNIVERSITY   (Belgium)

^f European Graduate School of Neuroscience   (Netherlands)

Author keywords

Brain derived neurotrophic factor; cytokine; hepatitis C, interferon ; major depressive disorder

Indexed keywords

ALPHA INTERFERON; AMANTADINE; BRAIN DERIVED NEUROTROPHIC FACTOR; CYTOKINE; INTERLEUKIN 1 RECEPTOR; INTERLEUKIN 10; INTERLEUKIN 6; INTERLEUKIN 8; PEGINTERFERON ALPHA2B; RECOMBINANT ALPHA2B INTERFERON; RIBAVIRIN; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; DEPRESSION; DRUG INDUCED DISEASE; FEMALE; HEPATITIS C; HUMAN; IMMUNE RESPONSE; MALE; MONTGOMERY ASBERG DEPRESSION RATING SCALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ANTIVIRAL AGENTS; BRAIN-DERIVED NEUROTROPHIC FACTOR; CYTOKINES; DEPRESSION; DEPRESSIVE DISORDER, MAJOR; FEMALE; HEPATITIS C, CHRONIC; HUMANS; HYDROCORTISONE; IMMUNOLOGIC FACTORS; INTERFERON-ALPHA; MALE; PSYCHIATRIC STATUS RATING SCALES; RIBAVIRIN; TIME FACTORS;

EID: 79952762081     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1017/S1461145710000830     Document Type: Article

References (47)

1. Anisman H (2009). Cascading effects of stressors and inflammatory immune system activation: implications for major depressive disorder. Journal of Psychiatry and Neuroscience 34, 4-20.
2. Asnis GM, De La Garza II R (2005). Interferon-induced depression: strategies in treatment. Progress in Neuropsychopharmacology and Biological Psychiatry 29, 808-818. (Pubitemid 40897798)
3. Asnis GM, De La Garza R (2006). Interferon-induced depression in chronic hepatitis C: a review of its prevalence, risk factors, biology, and treatment approaches. Journal of Clinical Gastroenterology 40, 322-335. (Pubitemid 44309525)
4. Aydemir C, Yalcin ES, Aksaray S, Kisa C, et al. (2006). Brain-derived neurotrophic factor (BDNF) changes in the serum of depressed women. Progress in Neuropsychopharmacology and Biological Psychiatry 30, 1256-1260. (Pubitemid 44216065)
5. Aydemir O, Deveci A, Taneli F (2005). The effect of chronic antidepressant treatment on serum brain-derived neurotrophic factor levels in depressed patients: a preliminary study. Progress in Neuropsychopharmacology and Biological Psychiatry 29, 261-265. (Pubitemid 40202912)
6. Barrientos RM, Sprunger DB, Campeau S, Higgins EA, et al. (2003). Brain-derived neurotrophic factor mRNA downregulation produced by social isolation is blocked by intrahippocampal interleukin-1 receptor antagonist. Neuroscience 121, 847-853. (Pubitemid 37324583)
7. Bocchio-Chiavetto L, Zanardini R, Bortolomasi M, Abate M, et al. (2006). Electroconvulsive therapy (ECT) increases serum brain derived neurotrophic factor (BDNF) in drug resistant depressed patients. European Neuropsychopharmacology 16, 620-624. (Pubitemid 44781079)
8. Bonaccorso S, Marino V, Puzella A, Pasquini M, et al. (2002). Increased depressive ratings in patients with hepatitis C receiving interferon-alpha-based immunotherapy are related to interferon-alpha-induced changes in the serotonergic system. Journal of Clinical Psychopharmacology 22, 86-90. (Pubitemid 34101297)
9. Bonaccorso S, Puzella A, Marino V, Pasquini M, et al. (2001). Immunotherapy with interferon-alpha in patients affected by chronic hepatitis C induces an intercorrelated stimulation of the cytokine network and an increase in depressive and anxiety symptoms. Psychiatry Research 105, 45-55. (Pubitemid 34015882)
10. Brassard DL, Grace MJ, Bordens RW (2002). Interferon-alpha as an immunotherapeutic protein. Journal of Leukocyte Biology 71, 565-581.
11. Brunoni AR, Lopes M, Fregni F (2008). A systematic review and meta-analysis of clinical studies on major depression and BDNF levels: implications for the role of neuroplasticity in depression. International Journal of Neuropsychopharmacology 11, 1169-1180.
12. Capuron L, Hauser P, Hinze-Selch D, Miller AH, et al. (2002a). Treatment of cytokine-induced depression. Brain Behavior and Immunity 16, 575-580. (Pubitemid 35333737)
13. Capuron L, Neurauter G, Musselman DL, Lawson DH, et al. (2003a). Interferon-alpha-induced changes in tryptophan metabolism. Relationship to depression and paroxetine treatment. Biological Psychiatry 54, 906-914.
14. Capuron L, Raison CL, Musselman DL, Lawson DH, et al. (2003b). Association of exaggerated HPA axis response to the initial injection of interferon-alpha with development of depression during interferon-alpha therapy. American Journal of Psychiatry 160, 1342-1345. (Pubitemid 41070955)
15. Capuron L, Ravaud A, Neveu PJ, Miller AH, et al. (2002b). Association between decreased serum tryptophan concentrations and depressive symptoms in cancer patients undergoing cytokine therapy. Molecular Psychiatry 7, 468-473. (Pubitemid 34712898)
16. Chen B, Dowlatshahi D, MacQueen GM, Wang JF, et al. (2001). Increased hippocampal BDNF immunoreactivity in subjects treated with antidepressant medication. Biological Psychiatry 50, 260-265. (Pubitemid 32778442)
17. De La Garza IIR, Asnis GM (2003). The non-steroidal anti-inflammatory drug diclofenac sodium attenuates IFN-alpha induced alterations to monoamine turnover in prefrontal cortex and hippocampus. Brain Research 977, 70-79. (Pubitemid 36638695)
18. Duman RS, Monteggia LM (2006). A neurotrophic model for stress-related mood disorders. Biological Psychiatry 59, 1116-1127.
19. Fujimura H, Altar CA, Chen R, Nakamura T, et al. (2002). Brain-derived neurotrophic factor is stored in human platelets and released by agonist stimulation. Thrombosis and Haemostasis 87, 728-734. (Pubitemid 34302963)
20. Gervasoni N, Aubry JM, Bondolfi G, Osiek C, et al. (2005). Partial normalization of serum brain-derived neurotrophic factor in remitted patients after a major depressive episode. Neuropsychobiology 51, 234-238. (Pubitemid 40976406)
21. Gonul AS, Akdeniz F, Taneli F, Donat O, et al. (2005). Effect of treatment on serum brain-derived neurotrophic factor levels in depressed patients. European Archives of Psychiatry and Clinical Neuroscience 255, 381-386. (Pubitemid 43029827)
22. Guan Z, Fang J (2006). Peripheral immune activation by lipopolysaccharide decreases neurotrophins in the cortex and hippocampus in rats. Brain Behavior and Immunity 20, 64-71. (Pubitemid 41814665)
23. Gunnar MR, Morison SJ, Chisholm K, Schuder M (2001). Salivary cortisol levels in children adopted from romanian orphanages. Development and Psychopathology 13, 611-628. (Pubitemid 33406346)
24. Hashimoto K, Shimizu E, Iyo M (2004). Critical role of brain-derived neurotrophic factor in mood disorders. Brain Research. Brain Research Reviews 45, 104-114. (Pubitemid 38625738)
25. Kaneko N, Kudo K, Mabuchi T, Takemoto K, et al. (2006). Suppression of cell proliferation by interferon-Alpha through interleukin-1 production in adult rat dentate gyrus. Neuropsychopharmacology 31, 2619-2626. (Pubitemid 44764159)
26. Karege F, Bondolfi G, GervasoniN, Schwald M, et al. (2005). Low brain-derived neurotrophic factor (BDNF) levels in serum of depressed patients probably results from lowered platelet BDNF release unrelated to platelet reactivity. Biological Psychiatry 57, 1068-1072. (Pubitemid 40613035)
27. Karege F, Perret G, Bondolfi G, Schwald M, et al. (2002a). Decreased serum brain-derived neurotrophic factor levels in major depressed patients. Psychiatry Research 109, 143-148. (Pubitemid 34258493)
28. Karege F, Schwald M, Cisse M (2002b). Postnatal developmental profile of brain-derived neurotrophic factor in rat brain and platelets. Neuroscience Letters 328, 261-264. (Pubitemid 34876661)
29. Kerschensteiner M, Gallmeier E, Behrens L, Leal VV, et al. (1999). Activated human T cells, B cells, and monocytes produce brain-derived neurotrophic factor in vitro and in inflammatory brain lesions: a neuroprotective role of inflammation? Journal of Experimental Medicine 189, 865-870. (Pubitemid 29189691)
30. Kitagami T, Yamada K, Miura H, Hashimoto R, et al. (2003). Mechanism of systemically injected interferon-alpha impeding monoamine biosynthesis in rats: role of nitric oxide as a signal crossing the blood-brain barrier. Brain Research 978, 104-114. (Pubitemid 36780963)
31. Lee J, Duan W, Mattson MP (2002). Evidence that brain-derived neurotrophic factor is required for basal neurogenesis and mediates, in part, the enhancement of neurogenesis by dietary restriction in the hippocampus of adult mice. Journal of Neurochemistry 82, 1367-1375.
32. Maddock C, Baita A, Orru MG, Sitzia R, et al. (2004). Psychopharmacological treatment of depression, anxiety, irritability and insomnia in patients receiving interferon-alpha: a prospective case series and a discussion of biological mechanisms. Journal of Psychopharmacology 18, 41-46. (Pubitemid 38623092)
33. Montgomery SA, Asberg M (1979). A new depression scale designed to be sensitive to change. British Journal of Psychiatry 134, 382-389. (Pubitemid 9136500)
34. Nakahashi T, Fujimura H, Altar CA, Li J, et al. (2000). Vascular endothelial cells synthesize and secrete brain-derived neurotrophic factor. FEBS Letters 470, 113-117. (Pubitemid 30151080)
35. Pan W, Banks WA, Fasold MB, Bluth J, et al. (1998). Transport of brain-derived neurotrophic factor across the blood-brain barrier. Neuropharmacology 37, 1553-1561. (Pubitemid 28550429)
36. Pan W, Banks WA, Kastin AJ (1997). Permeability of the blood-brain and blood-spinal cord barriers to interferons. Journal of Neuroimmunology 76, 105-111. (Pubitemid 27272635)
37. Prickaerts J, van den Hove DL, Fierens FL, Kia HK, et al. (2006). Chronic corticosterone manipulations in mice affect brain cell proliferation rates, but only partly affect BDNF protein levels. Neuroscience Letters 396, 12-16. (Pubitemid 43233779)
38. Raison CL, Capuron L, Miller AH (2006). Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends in Immunology 27, 24-31. (Pubitemid 43083561)
39. Schiepers OJ, Wichers MC, Maes M (2005). Cytokines and major depression. Progress in Neuropsychopharmacology and Biological Psychiatry 29, 201-217. (Pubitemid 40202906)
40. Schramm TM, Lawford BR, Macdonald GA, Cooksley WG (2000). Sertraline treatment of interferon-alfa-induced depressive disorder. Medical Journal of Australia 173, 359-361.
41. Sen S, Duman R, Sanacora G (2008). Serum brain-derived neurotrophic factor, depression, and antidepressant medications: meta-analyses and implications. Biological Psychiatry 64, 527-532.
42. ShimizuE, HashimotoK, Okamura N, Koike K, et al. (2003). Alterations of serum levels of brain-derived neurotrophic factor (BDNF) in depressed patients with or without antidepressants. Biological Psychiatry 54, 70-75. (Pubitemid 36776725)
43. Wichers M, Maes M (2002). The psychoneuroimmuno-pathophysiology of cytokine-induced depression in humans. International Journal of Neuropsychopharmacology 5, 375-388. (Pubitemid 35470357)
44. Wichers MC, Kenis G, Koek GH, Robaeys G, et al. (2007). Interferon-alpha-induced depressive symptoms are related to changes in the cytokine network but not to cortisol. Journal of Psychosomatic Research 62, 207-214. (Pubitemid 46161588)
45. Wichers MC, Koek GH, Robaeys G, Praamstra AJ, et al. (2005a). Early increase in vegetative symptoms predicts IFN-alpha-induced cognitive-depressive changes. Psychological Medicine 35, 433-441. (Pubitemid 40372481)
46. Wichers MC, Koek GH, Robaeys G, Verkerk R, et al. (2005b). IDO and interferon-alpha-induced depressive symptoms: a shift in hypothesis from tryptophan depletion to neurotoxicity. Molecular Psychiatry 10, 538-544. (Pubitemid 40897037)
47. Zanardini R, Gazzoli A, Ventriglia M, Perez J, et al. (2006). Effect of repetitive transcranial magnetic stimulation on serum brain derived neurotrophic factor in drug resistant depressed patients. Journal of Affective Disorders 91, 83-86. (Pubitemid 43254643)